These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 34296424)

  • 1. Iron reduces the propagation of pathological α-synuclein: An Editorial Highlight for "Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils" on page 554.
    Guo YJ; Ayton S; Lei P
    J Neurochem; 2021 Nov; 159(3):414-416. PubMed ID: 34296424
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Brain iron enrichment attenuates α-synuclein spreading after injection of preformed fibrils.
    Dauer Née Joppe K; Tatenhorst L; Caldi Gomes L; Zhang S; Parvaz M; Carboni E; Roser AE; El DeBakey H; Bähr M; Vogel-Mikuš K; Wang Ip C; Becker S; Zweckstetter M; Lingor P
    J Neurochem; 2021 Nov; 159(3):554-573. PubMed ID: 34176164
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Propagation of pathological α-synuclein in marmoset brain.
    Shimozawa A; Ono M; Takahara D; Tarutani A; Imura S; Masuda-Suzukake M; Higuchi M; Yanai K; Hisanaga SI; Hasegawa M
    Acta Neuropathol Commun; 2017 Feb; 5(1):12. PubMed ID: 28148299
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Copper and iron ions accelerate the prion-like propagation of α-synuclein: A vicious cycle in Parkinson's disease.
    Li Y; Yang C; Wang S; Yang D; Zhang Y; Xu L; Ma L; Zheng J; Petersen RB; Zheng L; Chen H; Huang K
    Int J Biol Macromol; 2020 Nov; 163():562-573. PubMed ID: 32629061
    [TBL] [Abstract][Full Text] [Related]  

  • 5. 14-3-3 Proteins Reduce Cell-to-Cell Transfer and Propagation of Pathogenic α-Synuclein.
    Wang B; Underwood R; Kamath A; Britain C; McFerrin MB; McLean PJ; Volpicelli-Daley LA; Whitaker RH; Placzek WJ; Becker K; Ma J; Yacoubian TA
    J Neurosci; 2018 Sep; 38(38):8211-8232. PubMed ID: 30093536
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intrastriatal alpha-synuclein fibrils in monkeys: spreading, imaging and neuropathological changes.
    Chu Y; Muller S; Tavares A; Barret O; Alagille D; Seibyl J; Tamagnan G; Marek K; Luk KC; Trojanowski JQ; Lee VMY; Kordower JH
    Brain; 2019 Nov; 142(11):3565-3579. PubMed ID: 31580415
    [TBL] [Abstract][Full Text] [Related]  

  • 7. α-Synuclein propagation leads to synaptic abnormalities in the cortex through microglial synapse phagocytosis.
    Pérez-Acuña D; Shin SJ; Rhee KH; Kim SJ; Lee SJ
    Mol Brain; 2023 Oct; 16(1):72. PubMed ID: 37848910
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Inoculation of α-synuclein preformed fibrils into the mouse gastrointestinal tract induces Lewy body-like aggregates in the brainstem via the vagus nerve.
    Uemura N; Yagi H; Uemura MT; Hatanaka Y; Yamakado H; Takahashi R
    Mol Neurodegener; 2018 May; 13(1):21. PubMed ID: 29751824
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Analysis of hemisphere-dependent effects of unilateral intrastriatal injection of α-synuclein pre-formed fibrils on mitochondrial protein levels, dynamics, and function.
    Creed RB; Memon AA; Komaragiri SP; Barodia SK; Goldberg MS
    Acta Neuropathol Commun; 2022 May; 10(1):78. PubMed ID: 35606853
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Decreased AQP4 Expression Aggravates ɑ-Synuclein Pathology in Parkinson's Disease Mice, Possibly via Impaired Glymphatic Clearance.
    Cui H; Wang W; Zheng X; Xia D; Liu H; Qin C; Tian H; Teng J
    J Mol Neurosci; 2021 Dec; 71(12):2500-2513. PubMed ID: 33772424
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Lack of pathogenic potential of peripheral α-synuclein aggregates from Parkinson's disease patients.
    Recasens A; Carballo-Carbajal I; Parent A; Bové J; Gelpi E; Tolosa E; Vila M
    Acta Neuropathol Commun; 2018 Feb; 6(1):8. PubMed ID: 29422109
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Are Preformed Fibrils a Model of Parkinson's Disease?
    Woerman AL; Luk KC
    J Parkinsons Dis; 2024; 14(6):1095-1103. PubMed ID: 39031387
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Novel naturally occurring autoantibodies attenuate α-synuclein pathology in a mouse model of Parkinson's disease.
    Li Y; Wang T; Meng L; Jin L; Liu C; Liang Y; Ren L; Liu Y; Liu Y; Liu S; Li T; Liang Y; Chen X; Zhang Z
    Neuropathol Appl Neurobiol; 2023 Feb; 49(1):e12860. PubMed ID: 36331758
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Gelsolin co-occurs with Lewy bodies in vivo and accelerates α-synuclein aggregation in vitro.
    Welander H; Bontha SV; Näsström T; Karlsson M; Nikolajeff F; Danzer K; Kostka M; Kalimo H; Lannfelt L; Ingelsson M; Bergström J
    Biochem Biophys Res Commun; 2011 Aug; 412(1):32-8. PubMed ID: 21798243
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Synapsin III is a key component of α-synuclein fibrils in Lewy bodies of PD brains.
    Longhena F; Faustini G; Varanita T; Zaltieri M; Porrini V; Tessari I; Poliani PL; Missale C; Borroni B; Padovani A; Bubacco L; Pizzi M; Spano P; Bellucci A
    Brain Pathol; 2018 Nov; 28(6):875-888. PubMed ID: 29330884
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structurally distinct α-synuclein fibrils induce robust parkinsonian pathology.
    Hayakawa H; Nakatani R; Ikenaka K; Aguirre C; Choong CJ; Tsuda H; Nagano S; Koike M; Ikeuchi T; Hasegawa M; Papa SM; Nagai Y; Mochizuki H; Baba K
    Mov Disord; 2020 Feb; 35(2):256-267. PubMed ID: 31643109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Extracellular clusterin limits the uptake of α-synuclein fibrils by murine and human astrocytes.
    Filippini A; Mutti V; Faustini G; Longhena F; Ramazzina I; Rizzi F; Kaganovich A; Roosen DA; Landeck N; Duffy M; Tessari I; Bono F; Fiorentini C; Greggio E; Bubacco L; Bellucci A; Missale M; Cookson MR; Gennarelli M; Russo I
    Glia; 2021 Mar; 69(3):681-696. PubMed ID: 33045109
    [TBL] [Abstract][Full Text] [Related]  

  • 18. α-Synuclein Preformed Fibrils Bind to β-Neurexins and Impair β-Neurexin-Mediated Presynaptic Organization.
    Feller B; Fallon A; Luo W; Nguyen PT; Shlaifer I; Lee AK; Chofflet N; Yi N; Khaled H; Karkout S; Bourgault S; Durcan TM; Takahashi H
    Cells; 2023 Apr; 12(7):. PubMed ID: 37048156
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Leveraging the preformed fibril model to distinguish between alpha-synuclein inclusion- and nigrostriatal degeneration-associated immunogenicity.
    Stoll AC; Sortwell CE
    Neurobiol Dis; 2022 Sep; 171():105804. PubMed ID: 35764290
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Trans-synaptic and retrograde axonal spread of Lewy pathology following pre-formed fibril injection in an in vivo A53T alpha-synuclein mouse model of synucleinopathy.
    Schaser AJ; Stackhouse TL; Weston LJ; Kerstein PC; Osterberg VR; López CS; Dickson DW; Luk KC; Meshul CK; Woltjer RL; Unni VK
    Acta Neuropathol Commun; 2020 Aug; 8(1):150. PubMed ID: 32859276
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.